2024 Webinar: Revised Draft Appendix 1 of FDA’s Preventive Controls for Human Foods Guidance
The U.S. Food and Drug Administration (FDA) released the long-anticipated revised draft “Appendix 1” of the multi-chapter draft guidance for industry titled Hazard Analysis and Risk-Based Preventive Controls for Human Food: Draft Guidance for Industry on January 30, 2024. Since the initial publication of “Appendix 1”, many food industry groups, including ASTA, advocated for FDA to update the guidance to make corrections, reflect the latest scientific evidence, and minimize confusion and inconsistencies. The updated draft includes a number of notable revisions to potential hazards in spices and seasonings and guidance on hazard analysis for spices, including several updates that were requested by ASTA. The “Appendix 1” guidance has significant implications for FDA food facility inspections, as it is used as a key reference by inspectors. This 45-minute webinar provides the latest updates on how they may impact your food safety plan and facility inspections.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
Navigating Heavy Metals in Food Safety Plans
Presented at ASTA's 2024 Regulatory Workshop, this session explored the implications of FDA’s revised Appendix 1, which identifies heavy metals as a potential hazard requiring a preventive control for spices. It also explored real-life case studies and provided discussion with industry colleagues on how to best consider heavy metals in their risk management strategy.
ASTA Ready-to-Eat FAQs
The microbial safety of “ready-to-eat” (RTE) foods is a hot topic that ASTA is hearing a lot about when it comes to implementation of the Food Safety Modernization Act (FSMA). The U.S. Food and Drug Administration (FDA) has not yet published guidance regarding classifying and processing RTE foods. In these “frequently asked questions” (FAQs), ASTA is sharing information on positions FDA could take on RTE based on the preambles to the FSMA final rules, talks that FDA officials have given, information published in the update to the spice draft risk profile, informal conversations with FDA officials, and other published FDA draft guidance. ASTA has produced these FAQs in order to help members understand FDA’s current thinking on RTE foods, but we note that we have not received input on this document from FDA.
